back-office Open An Account
partner-with-us Partner with Us
Corporate Actions
MPS acquires US-based Unbound Medicine

31-Jan-26   09:14 Hrs IST
The acquisition will be executed through MPS North America LLC, a wholly owned subsidiary of MPS. The transaction is expected to be completed on or before 10 February 2026, subject to the fulfilment of customary closing conditions, the company said in a regulatory filing.

The acquisition will be carried out for a cash consideration of $16.50 million, subject to customary adjustments.

Founded in 1999, Unbound Medicine provides digital medical reference tools, clinical decision-support solutions and healthcare learning platforms. Its services are delivered through proprietary mobile and web-based platforms and follow a subscription-led institutional business model. The company serves medical schools, hospital systems and healthcare associations across the United States and Canada.

MPS said the acquisition aligns with its strategy of building platform-led, recurring-revenue businesses. The transaction is expected to support revenue diversification, enable cross-selling opportunities and strengthen the company's presence in the North American market.

MPS provides learning and platform solutions combining content, technology and artificial intelligence. The company is focused on scaling operations and strengthening its position in the global learning and knowledge services market.

On a consolidated basis, net profit of MPS rose 57.32% to Rs 55.44 crore while net sales rose 9.42% to Rs 194.44 crore in Q2 September 2025 over Q2 September 2024.

Shares of MPS rose 3.46% to settle at Rs 1884.80 on Friday, 30 January 2026.

Powered by Capital Market - Live News

Attention Investors: Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.|| KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.|| No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.